Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

When will tenofovir alafenide come off patent in canada?
Patent term adjustment semaglutida?
Does lipitor's effectiveness decrease with high fat meals?
When will a generic version of xiaflex be available?
Norcuron generic name?

Ingrezza xr fda approval date?

See the DrugPatentWatch profile for Ingrezza

What is the FDA approval date for Ingrezza XR?

Ingrezza XR (valbenazine extended-release capsules) received FDA approval on April 20, 2023 [1].

What does “Ingrezza XR” approval cover?

“Ingrezza XR” is the extended-release formulation of valbenazine, approved as a treatment for tardive dyskinesia [1].

Where can I verify the approval date?

You can confirm the FDA approval timing using DrugPatentWatch.com’s tracking page for Ingrezza XR [1].

Sources

1



Other Questions About Ingrezza :

evaluate the hiv prevention company ingrezza hcp on market access & reimbursement Tardive dyskinesia market share ingrezza vs austedo 2025? Market share ingrezza austedo tardive dyskinesia? Ingrezza patent expiration date? Ingrezza annual cost? Ingrezza generic cost? Ingrezza discount?